Ian M. Estepan
2020
Compensation breakdown
| Non-Equity Incentive Plan | $205,549 |
|---|---|
| Option Awards | $4,058,579 |
| Salary | $445,822 |
| Stock Awards | $434,986 |
| Other | $32,744 |
| Total | $5,177,681 |
Estepan received $4.1M in option awards, accounting for 78% of the total pay in 2020.
Estepan also received $205.5K in non-equity incentive plan, $445.8K in salary, $435K in stock awards and $32.7K in other compensation.
Rankings
In 2020, Ian M. Estepan's compensation ranked 2,125th out of 13,090 executives tracked by ExecPay. In other words, Estepan earned more than 83.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,125 out of 13,090 | 84th |
Division Manufacturing | 813 out of 5,620 | 86th |
Major group Chemicals And Allied Products | 290 out of 2,253 | 87th |
Industry group Drugs | 246 out of 1,953 | 87th |
Industry Pharmaceutical Preparations | 175 out of 1,458 | 88th |
Pay ratio
| Ian M. Estepan's Pay | $5,177,681 |
|---|---|
| Median Employee's Pay | $275,247 |
| Pay Ratio | 19to 1 |
In 2020, the annual total compensation of Ian M. Estepan was $5,177,681.
The annual total compensation of the median employee at Sarepta Therapeutics was $275,247.
The ratio of Ian M. Estepan's pay to the pay of median employee was therefore 19 to one.
Estepan's colleagues
We found seven more compensation records of executives who worked with Ian M. Estepan at Sarepta Therapeutics in 2020.
2020
Louise Rodino-Klapac
Sarepta Therapeutics
Chief Scientific Officer
2020
David Howton
Sarepta Therapeutics
General Counsel
2020
Gilmore MMSc
Sarepta Therapeutics
Chief Scientific Officer
2020
Sandesh Mahatme
Sarepta Therapeutics
Chief Financial Officer
2020
Douglas Ingram
Sarepta Therapeutics
Chief Executive Officer
2020
Joseph Bratica
Sarepta Therapeutics
Vice President, Corporate Controller
2020
William Ciambrone
Sarepta Therapeutics